![Steven Theriault](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Fortuna: 600 $ al 31/05/2026
Steven Theriault is currently Director, Chief Executive & Science Officer at Cytophage Technologies Ltd. since 2024.
Formerly, Dr. Theriault was Chief Executive & Science Officer at Cytophage Technologies, Inc. (Old).
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
| 31/07/2025 | 150.000 ( 0,24 % ) | 600 $ | 31/05/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| CYTOPHAGE TECHNOLOGIES LTD. | Director Ejecutivo | 02/02/2024 |
| Empresas | Cargo | Fin |
|---|---|---|
Cytophage Technologies, Inc. (Old)
 Cytophage Technologies, Inc. (Old) BiotechnologyHealth Technology Operates as a biotechnology company | Director Ejecutivo | - |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 2 |
|---|---|
Cytophage Technologies, Inc. (Old)
Cytophage Technologies, Inc. (Old) BiotechnologyHealth Technology Operates as a biotechnology company | Health Technology |
Cytophage Technologies Ltd.
 Cytophage Technologies Ltd. Financial ConglomeratesFinance Produces bacteriophages for bacterial infections and diseases | Finance |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.
